From the Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina (K.R., T.E.M.); Anesthesiology Service, Durham Veterans Affairs Medical Center, Durham, North Carolina (K.R.); Department of Anesthesiology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania (A.B.); OptiStatim, LLC, Longmeadow, Massachusetts (B.H.N.); RTI International, Research Triangle Park, North Carolina (C.A.B.); Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee (A.D.S.); Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (M.A.B.); and Department of Medicine, Center for Quality of Care Research, Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts (P.K.L.).
Anesthesiology. 2015 Dec;123(6):1385-93. doi: 10.1097/ALN.0000000000000861.
Currently, guidelines recommend initial resuscitation with intravenous (IV) crystalloids during severe sepsis/septic shock. Albumin is suggested as an alternative. However, fluid mixtures are often used in practice, and it is unclear whether the specific mixture of IV fluids used impacts outcomes. The objective of this study is to test the hypothesis that the specific mixture of IV fluids used during initial resuscitation, in severe sepsis, is associated with important in-hospital outcomes.
Retrospective cohort study includes patients with severe sepsis who were resuscitated with at least 2 l of crystalloids and vasopressors by hospital day 2, patients who had not undergone any major surgical procedures, and patients who had a hospital length of stay (LOS) of at least 2 days. Inverse probability weighting, propensity score matching, and hierarchical regression methods were used for risk adjustment. Patients were grouped into four exposure categories: recipients of isotonic saline alone ("Sal" exclusively), saline in combination with balanced crystalloids ("Sal + Bal"), saline in combination with colloids ("Sal + Col"), or saline in combination with balanced crystalloids and colloids ("Sal + Bal + Col"). In-hospital mortality was the primary outcome, and hospital LOS and costs per day (among survivors) were secondary outcomes.
In risk-adjusted Inverse Probability Weighting analyses including 60,734 adults admitted to 360 intensive care units across the United States between January 2006 and December 2010, in-hospital mortality was intermediate in the Sal group (20.2%), lower in the Sal + Bal group (17.7%, P < 0.001), higher in the Sal + Col group (24.2%, P < 0.001), and similar in the Sal + Bal + Col group (19.2%, P = 0.401). In pairwise propensity score-matched comparisons, the administration of balanced crystalloids by hospital day 2 was consistently associated with lower mortality, whether colloids were used (relative risk, 0.84; 95% CI, 0.76 to 0.92) or not (relative risk, 0.79; 95% CI, 0.70 to 0.89). The association between colloid use and in-hospital mortality was inconsistent, and survival was not uniformly affected, whereas LOS and costs per day were uniformly increased. Results were robust in sensitivity analyses.
During the initial resuscitation of adults with severe sepsis/septic shock, the types of IV fluids used may impact in-hospital mortality. When compared with the administration of isotonic saline exclusively during resuscitation, the coadministration of balanced crystalloids is associated with lower in-hospital mortality and no difference in LOS or costs per day. When colloids are coadministered, LOS and costs per day are increased without improved survival. A large randomized controlled trial evaluating crystalloid choice is warranted. Meanwhile, the use of balanced crystalloids seems reasonable. (Anesthesiology 2015; 123:1385-93).
目前,指南建议在严重脓毒症/感染性休克期间通过静脉(IV)晶体进行初始复苏。白蛋白被建议作为替代物。然而,在实践中经常使用混合液,并且尚不清楚使用的 IV 液的特定混合物是否会影响结果。本研究的目的是检验以下假设,即在严重脓毒症的初始复苏期间使用的 IV 液的特定混合物与重要的院内结局有关。
回顾性队列研究纳入了至少接受 2 L 晶体和升压药复苏的严重脓毒症患者,研究对象在第 2 天之前没有接受任何主要手术,并且住院时间( LOS )至少为 2 天。使用逆概率加权、倾向评分匹配和层次回归方法进行风险调整。将患者分为四组暴露类别:单独接受等渗盐水的患者(“ Sal ”专用)、盐水与平衡晶体的组合(“ Sal + Bal ”)、盐水与胶体的组合(“ Sal + Col ”)或盐水与平衡晶体和胶体的组合(“ Sal + Bal + Col ”)。院内死亡率为主要结局,住院 LOS 和幸存者每天的费用(成本)为次要结局。
在包括 2006 年 1 月至 2010 年 12 月期间在美国 360 个重症监护病房住院的 60734 名成年人的风险调整逆概率加权分析中,院内死亡率在 Sal 组为中等(20.2%),Sal + Bal 组较低(17.7%,P <0.001),Sal + Col 组较高(24.2%,P <0.001),Sal + Bal + Col 组相似(19.2%,P = 0.401)。在成对的倾向评分匹配比较中,在第 2 天使用平衡晶体始终与死亡率降低相关,无论是否使用胶体(相对风险,0.84;95%置信区间,0.76 至 0.92)。胶体使用与院内死亡率之间的关联不一致,生存率并未均匀受到影响,而 LOS 和每天的费用则均匀增加。敏感性分析结果稳健。
在严重脓毒症/感染性休克患者的初始复苏期间,使用的 IV 液类型可能会影响院内死亡率。与单独复苏时使用等渗盐水相比,同时给予平衡晶体与较低的院内死亡率相关,且 LOS 和每天的费用无差异。当同时使用胶体时,尽管没有改善生存率,但 LOS 和每天的费用会增加。需要进行大型随机对照试验来评估晶体选择。同时,使用平衡晶体似乎是合理的。(麻醉学 2015 年;123:1385-93)。